Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

REVELATION BIOSCIENCES INC (REVBW)

7 + Investors. Track Smart Money conviction in REVBW. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -4
Streak
1Q ▼
Buyers last Q
38%

Smart Money Signals — REVBW

Based on 7 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their REVBW positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🔻

Below peak — only 54% of 3.0Y high

54% of all-time peak
Only 7 funds hold REVBW today versus a peak of 13 funds at 2024 Q2 — just 54% of the maximum. Low institutional ownership can mean the stock is out of favor, but it also means there's a large pool of potential buyers if sentiment turns.
📉

Outflows — 22% fewer funds vs a year ago

fund count last 6Q
2 fewer hedge funds hold REVBW compared to a year ago (-22% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🔴

Heavy selling pressure — only 38% buying

3 buying5 selling
Last quarter: 5 funds sold vs only 3 buyers. This is widespread institutional distribution — not a few funds rebalancing, but a broad exit. High conviction bearish signal.
➡️

Steady new buyers — ~1 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 4 → 1 → 2 → 1. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

57% of holders stayed for 2+ years

57% conviction (2yr+) 43% medium 0% new
4 out of 7 hedge funds have held REVBW for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
📊

Peak discovery — momentum slowing

2 → 4 → 1 → 2 → 1 new funds/Q
New funds entering each quarter: 4 → 1 → 2 → 1. REVBW is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.
🏛️

Deep conviction — 57% of holders stayed 2+ years

57% veterans 0% 1-2yr 43% new
Of 7 current holders: 4 (57%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.

Strong quality — 28% AUM from major funds

28% from top-100 AUM funds
3 of 7 holders rank in the top 100 by AUM, accounting for 28% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
1.3
out of 10
Low Exit Risk
Exit risk score 1.3/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — REVBW

In 2026 Q1, 3 hedge funds were net buyers of REVBW (1 opened a new position, 2 added to an existing one), while 5 reduced or exited (5 sold completely) — a 38% buyer ratio, indicating net institutional distribution. 28% of total institutional value in REVBW is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: -4 funds (more exits than new entries). Total institutional holders: 7.

Hedge Fund Ownership: REVBW

How many hedge funds hold REVBW — quarterly history vs. share price
Quarterly hedge fund ownership of REVBW vs. share price

Market Analysis: REVBW

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: REVBW

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy REVELATION BIOSCIENCES INC (REVBW) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much REVBW has moved relative to its sector benchmark (SPY) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 64d ago
REVBW
+37.1%
SPY
+16.8%

REVBW outperformed SPY by +20.3% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 19d ago
REVBW
+26.4%
SPY
+2.7%

Since the filing became public, REVBW outperformed SPY by +23.7% .

Interpretation: The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

0 top-rated funds 0 high-conviction
Consensus
0.0
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: REVBW
7 + Investors

Track Smart Money conviction in REVBW. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 7 11 -36.36%
13F Shares 285K 1M -78.3%
Total Value $2K $11K -78.08%
New Positions 1 2 -1
Increased Positions 2 1 +1
Closed Positions 5 1 +4
Reduced Positions 0 1 -1
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: REVBW

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

7 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in REVBW. Verified SEC 13F-HR filings.

QUARTER:
Top 7 institutional holders of REVBW — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Soltis Investment Advisors LLC 0.00% 47,500
2 WOLVERINE ASSET MANAGEMENT LLC 0.00% 54,752
3 TORONTO DOMINION BANK 0.00% 99,550
4 Quaker Wealth Management, LLC 0.00% 387
5 JANE STREET GROUP, LLC 0.00% 50,000
6 CITADEL ADVISORS LLC 0.00% 32,400
7 UBS Group AG 0.00% 532
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — REVELATION BIOSCIENCES INC (REVBW)

What does the Smart Money Trend signal show for REVBW?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their REVBW positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for REVBW?

Heavy selling pressure — only 38% buying: Last quarter: 5 funds sold vs only 3 buyers. This is widespread institutional distribution — not a few funds rebalancing, but a broad exit. High conviction bearish signal.

What is the fund quality score for REVBW holders?

Strong quality — 28% AUM from major funds: 3 of 7 holders rank in the top 100 by AUM, accounting for 28% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held REVBW?

57% of holders stayed for 2+ years: 4 out of 7 hedge funds have held REVBW for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy REVELATION BIOSCIENCES INC (REVBW) following the 2026 Q1 hedge fund 13F filings?

As of today, REVBW has moved +26.4% since the 2026 Q1 13F filing date (May 15, 2026), compared to +2.7% for the SPY sector ETF — an outperformance of +23.7%. Since the quarter end (March 31, 2026), REVBW has gained +37.1% vs +16.8% for SPY. The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →